Earlier investigations have shown that GLP-1 (Glucagon-like Peptide-1) analogs exhibit neuroprotective qualities in various models of neurological diseases, encompassing conditions such as Alzheimers disease, Parkinsons disease, and stroke
Some patients use a GLP-1 medication for a defined period to reach a goal, reset their relationship with food, and build sustainable habits and then taper off successfully
The fear of potential side effects from similar drugs can also cause anxiety in patients who rely on these medications for their health management
NICE flags as the better target
If you are ever unsure about how a new medication might interact with your treatment, we are here to offer guidance
Avoid overeating, skipping protein, and ignoring hydration